Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 10Sarcoma 1Gastrointestinal 1

Conditions

Sarcoma 1336Glioblastoma 493Gliosarcoma 470Osteosarcoma 363Brain Neoplasms 321Central Nervous System Neoplasms 276Astrocytoma 262Dendritic Cell Sarcoma, Interdigitating 258Gastrointestinal Stromal Tumors 251Neoplasms 231Glioma 229Lymphoma 226Neuroblastoma 209Rhabdomyosarcoma 208Breast Neoplasms 204Sarcoma, Ewing 202Recurrence 202Burkitt Lymphoma 198Lymphoma, Non-Hodgkin 196Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Oligodendroglioma 192Melanoma 182Ovarian Neoplasms 175Lymphoma, Large B-Cell, Diffuse 173Neoplasm Metastasis 172Bone Neoplasms 168Lymphoma, Follicular 158Leukemia, Lymphocytic, Chronic, B-Cell 144Lymphoma, Mantle-Cell 143Liposarcoma 143

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Cancer × Sarcoma × Clear all
NCT05154630 2024-01-18

Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Terminated
8 enrolled
Sarcoma

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡